Exercise, inflammation, and fatigue in cancer survivors

Autor/innen

  • Emily C. P. LaVoy Univ Houston, Dept Hlth & Human Performance, Lab Integrated Physiol, 3875 Holman St, Houston, TX 77204 USA Autor/in
  • Christopher P. Fagundes Rice Univ, Dept Psychol, Houston, TX 77251 USA Autor/in
  • Robert Dantzer Univ Texas MD Anderson Canc Ctr, Dept Symptom Res, Div Internal Med, Houston, TX 77030 USA Autor/in

DOI:

https://doi.org/10.22029/eir.2016.1710

Schlagwörter:

HEART-RATE-VARIABILITY, QUALITY-OF-LIFE, RANDOMIZED CONTROLLED-TRIAL, DIURNAL CORTISOL RHYTHM, BREAST-CANCER, PHYSICAL-ACTIVITY, LONG-TERM, AUTONOMIC DYSFUNCTION, CHANGE INTERVENTION, MULTIPLE-SCLEROSIS

Abstract

Cancer-related fatigue significantly disrupts normal functioning and quality of life for a substantial portion of cancer survivors, and may persist for years following cancer treatment. While the causes of persistent fatigue among cancer survivors are not yet fully understood, accumulating evidence suggests that several pathways, including chronic inflammation, autonomic imbalance, HPA-axis dysfunction, and/or mitochondrial damage, could contribute towards the disruption of normal neuronal function and result in the symptom of cancer-related fatigue. Exercise training interventions have been shown to be some of the more successful treatment options to address cancer-related fatigue. In this review, we discuss the literature regarding the causes of persistent fatigue in cancer survivors and the mechanisms by which exercise may relieve this symptom. There is still much work to be done until the prescription of exercise becomes standard practice for cancer survivors. With improvements in the quality of studies, evidenced-based exercise interventions will allow exercise scientists and oncologists to work together to treat cancer-related fatigue.

Literaturhinweise

Veröffentlicht

2026-07-15

Ausgabe

Rubrik

Articles